Our vision
Welcome to Capital Cell, Europe's leading alternative investment platform for the Life Sciences and Biotechnology sector.
At Capital Cell we believe in the power of smart investments to shape a better future for all. Expertly selected and backed by innovation leaders, we offer you the unique opportunity to be at the forefront of the biotech revolution. Our mission is to democratize access to high-impact, high-return investments in the life sciences, making it possible for anyone to contribute to the next breakthrough in human health.
Capital Cell was born in 2015 in the scientific ecosystem of Barcelona, and has since become one of the largest investors in biotech startups in Europe, always with the ambition to globally drive innovation in health and biotechnology.
Our values
Excellence
We rely on a global network of over 3,500 scientists, doctors and investment experts to meticulously screen and select only the most promising companies. Only 3% of the companies that contact us make it to our platform, ensuring that your investments are in the best hands.
Innovation
We are excited to be part of a rapidly evolving biotechnology sector. The companies in which we invest are developing cutting-edge diagnostics, treatments and tools that have the potential to transform healthcare on a global scale.
Impact
Investing with Capital Cell is about more than making a financial return: it is about making a meaningful contribution to society. Our platform allows you to support pioneering scientific research that can improve lives around the world, and generate value for the society.
Accessibility
We believe that everyone should have the opportunity to invest in biotechnology and life sciences. Our platform minimizes barriers to entry, allowing individual private investors to participate alongside specialized investment funds and specialized investors.
The team
Biologist turned entrepreneur and financier, Daniel Oliver is the founder and director of Capital Cell.
Daniel Oliver
🇬🇧 🇲🇫 🇪🇸 🇮🇹
Director
With more than 20 years of experience in high-tech management, Julien leads the operations of Capital Cell in France.
Julien Gillet-Daubin
🇫🇷 🇬🇧
Director, France
Heidi Rohwer PhD is in charge of the BioExpert Network, the global network of experts that analyzes and validates all investments.
Heidi Rohwer, Phd
🇬🇧 🇩🇪 🇪🇸
Coordinator of the BioExpert Network
Marc is in charge of the relationship with private investors, Business Angels and Family Offices.
Marc Armet
🇬🇧 🇪🇸
Investor Relations Director
Riccardo, a highly experienced lawyer and investor, leads the company's operations in Italy.
Riccardo Aimerito
🇬🇧 🇮🇹 🇲🇫
Director, Italy
Trained in biosciences and specialized in the pharmaceutical and biotech industry, Mariona ensures the quality of the campaigns published.
Mariona Vidal-Picamoles
🇬🇧 🇲🇫 🇪🇸
Campaign Manager
With a strong background in life sciences business development and investment, Nicky leads the operations of Capital Cell in the Benelux.
Nicky Rijk-Vogels
🇬🇧 🇳🇱
Director, Benelux
Naira is in charge of the relationship with institutions, investors and international strategic partners of the company.
Naira França
🇬🇧 🇵🇹 🇪🇸
Investor Relations
Brais, a chemical engineer by training, switched from managing industrial facilities to operations management in Capital Cell.
Brais Alfaya
🇬🇧 🇪🇸
Operations
One of Europe's leading experts in crowdfunding regulation, Oriol handles all legal issues.
Oriol Cordon
🇬🇧 🇪🇸
Legal
In addition to being responsible for technology, Joan has also been a partner and advisor to the company since 2016.
Joan Marcos
🇬🇧 🇪🇸
CTO
Partners, advisors and friends
Jordi Riulas
Jordi is a successful entrepreneur, investor and advisor. He was part of the Center for Genomic Regulation in Barcelona. He brings to Capital Cell his knowledge, passion for biotechnology, as well as his know-how in scaling businesses.
Nigel Fleming
Nigel has an extensive track record in biotech start-ups. He is on the board of 12 companies, 7 of which he founded. He is a founder of Athena Diagnostics, which sold for $740 million, professor at Harvard Medical School and ESADE, and co-inventor of 8 patents.
Dr. John Bethell
Doctor, entrepreneur and recruitment leader. Co-founder of international medical recruitment firms, Wavelength International & Ccentric. Advisor to early-stage biotech and medtech startups on team growth strategies.
Alternative investments: diversify your portfolio with impact
We invite you to join us in shaping the future of health.
Whether you are an investor looking to diversify your portfolio and generate positive social impact, or a biotech company looking for capital to scale, Capital Cell is your partner in this exciting journey. Together, we can lead the global revolution in healthcare.
Partner With Us
If our mission inspires you, we invite you to explore the opportunities of investing with Capital Cell.
Here you can put your capital to work to drive scientific progress, create impact investments and achieve potential returns well above the rest of your portfolio. Connect with us and be part of a community that is betting on the future of medicine.
Want to know more about Capital Cell?
How we work
Investors who join our platform have access to qualified investment opportunities carefully analyzed by experts, and are provided with extensive information on each of their investments.
For leading companies looking for investment to grow, Capital Cell offers more than just a funding platform: it is a point of contact with a network of committed investors who provide much more than just capital.
Who we are
Founded to provide everyone with access to biotechnology and healthcare investments, Capital Cell has created an investment product designed to enable everyone to participate with confidence in this complex but highly profitable sector.
For the innovation leaders in biotech seeking capital, Capital Cell presents a fundraising platform that connects to a network of private and institutional investors, complemented by expert guidance in science, investment and tech.
Why trust Capital Cell
Our carefully selected investment opportunities are designed to multiply our shareholders' capital, with portfolio appreciation of x3 to date and an internal rate of return (IRR) that exceeds the 30-year average of the S&P500 (adjusted for inflation).
Who we work with
Investing with Capital Cell means being part of a visionary network dedicated to transforming medicine. From renowned medical centers, hospitals and academic research institutions to world-class commercial, legal and infrastructure partners, we work with the world's leading experts to deliver unique and innovative investments.
Who invests with us
Our investors are a diverse and specialized group, ranging from venture capital funds to individual investors, each bringing a wealth of experience and a passion for innovation.
You’ll invest alongside leading venture capital funds, business angels, family offices, universities, regional development funds, and accelerators.
